In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp.

The in vitro activities of ravuconazole and voriconazole were compared with those of amphotericin B, flucytosine (5FC), itraconazole, and fluconazole against 6,970 isolates of Candida spp. obtained from over 200 medical centers worldwide. Both ravuconazole and voriconazole were very active against a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., Diekema, D. J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2002
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC127275/
https://ncbi.nlm.nih.gov/pubmed/12019081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1723-1727.2002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados